Background/Aims Age-related macular degeneration (AMD) is the main cause of visual
impairment and blindness in Europe. A further increase in the number of affected persons is …

Among older adults, age-related macular degeneration (AMD) is a prevalent disabling
condition that begins as subtle visual disturbances and can progress to permanent loss of …

Purpose Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly
of European ancestry. Risk profiles and treatment options have changed considerably over …

Purpose Age-related macular degeneration (AMD) is a common threat to vision. While
classification of disease stages is critical to understanding disease risk and progression …

Mutations in the PTEN-induced kinase 1 (PINK1) and Parkin RBR E3 ubiquitin-protein
ligase (PARKIN) genes are associated with familial forms of Parkinson's disease (PD) …

Age-related macular degeneration (AMD) is a serious degenerative disease affecting the
eyes, and is the main cause of severe vision loss among people> 55 years of age in …

Purpose To develop a genotype assay to assess associations with common and rare age-
related macular degeneration (AMD) risk variants, to calculate an overall genetic risk score …

The pathogenesis of age-related macular degeneration (AMD), a leading cause of blindness
worldwide, remains only partially understood. This has led to the current lack of accessible …

Objectives This study aimed to characterize the association of lifestyle and nutritional risk
profiles with age-related macular degeneration (AMD) in two subpopulations with differing …

Purpose To differentiate the plasma metabolomic profile of patients with age related macular
degeneration (AMD) from that of controls, by Nuclear Magnetic Resonance (NMR) …